लोड हो रहा है...

Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells

Genetically engineered oncolytic herpes simplex virus-1 (HSV-1) vectors selectively replicate in tumor cells causing direct killing whereas sparing normal cells. One clinical limitation of using oncolytic HSV vectors is their attenuated growth. We hypothesized that the appropriately chosen chemother...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Passer, BJ, Castelo-Branco, P, Buhrman, JS, Varghese, S, Rabkin, SD, Martuza, RL
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2009
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2843507/
https://ncbi.nlm.nih.gov/pubmed/19197321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cgt.2009.10
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!